GobblesGobbles

Ryan Cole, the "immortality elixir," and a very public flip

2 min readPublishes every 2 days1 sourceAI-written, source-linked. Learn moreNot medical advice. Talk to your doctor before changing care.

2025: a republished post says a "DNA rejuvenation elixir" cooked up at Harvard was greenlit by MAHA-FDA for first-in-human trials.

Ryan Cole, the "immortality elixir," and a very public flip

A republished post says the Independent Medical Alliance and Dr. Ryan Cole promoted an "immortality elixir" on a podcast — the same Ryan Cole who had previously criticized mRNA shots, flagged cancer risk, and named SV40 as a known carcinogenicity agent. The product in question is a "rejuvenating, DNA correcting, epi-genetic" mRNA shot delivered into the eye, containing SV40. It also requires a continuous regimen of antibiotics and steroids, taken indefinitely.

Gobbles Gobble's Take: From "SV40 causes cancer" to "SV40 in my eye, please" is quite the character arc. Source: Perplexity Search (community news)


Life Bio, partial epigenetic reprogramming, and the first human test

On January 27, the press announced a longevity milestone: MAHA-FDA greenlights study on a "near total reset" of cells. Life Biosciences and its approach — partial epigenetic reprogramming — will be the first to test the concept in humans, under the broader banner of "cellular rejuvenation." Altos Labs, backed by billions including reportedly Amazon's Jeff Bezos, is working on its own version.

Gobbles Gobble's Take: The branding keeps getting grander. The human data remains, charmingly, pending. Source: Perplexity Search (community news)


In Case You Missed It

Yesterday's top stories:

Was this briefing useful?

One tap helps Gobbles learn what to cover more carefully.

Get Longevity Lab in your inbox

Free daily briefing. No spam. Unsubscribe anytime.

See something wrong? Report an inaccuracy